New AAP Guidance: Exome and genome sequencing recommended as first-line tests. Learn more
This NICU Awareness Month, GeneDx celebrates the healthcare heroes navigating some of the most challenging beginnings—and is here to help.
August 27, 2025 • 3 min read
In the NICU, every moment matters. We are aware of the stakes you face each day—finding answers for critically ill newborns with complex, often puzzling presentations—and how critical it is to get it right the first time.
That’s a tremendous amount of responsibility, one you carry alongside the fragile lives in your care in your NICU.
We see you and we celebrate that tireless dedication. And we’re here to help.
Like you, we’re here in service of the same goal: helping every newborn get the best possible start. The NICU may be where the journey begins, but together, we can help shape where it goes next.
This NICU Awareness Month, we’re celebrating your tireless dedication and shining a light on the recent SeqFirst-neo study1 (originally published in the American Journal of Human Genetics), which shows how broad access to rapid genomic sequencing can change the trajectory for newborns when the cause of illness is unclear. This simple protocol led to significantly more diagnoses than conventional care:
That’s why GeneDx offers rapid and ultraRapid genome sequencing, which can give results in as soon as 2 days.*
Early genome sequencing has the power of timely diagnosis, quickly identifying an infant’s underlying genetic disease. Those health insights can help you move from tests to treatments.
1 in 3 infants in the NICU likely have a genetic disorder1
Rapid genomic sequencing is currently ordered for fewer than 5% of eligible pediatric patients2
90% of diagnoses made by rapid genome sequencing could not have been predicted by clinical features alone3
We know that every diagnosis represents countless hours of dedication from you and your team. Our role is to stand alongside you, offering the genomic insights you need to move from uncertainty to action. Because clearer, faster answers can help reduce unnecessary interventions, inform timely care decisions, and support better outcomes for critically ill infants.
Discover how genome-first testing can support your NICU care decisions.
Reference: 1. Wenger T, Scott A, Kruidenier L, et al. Am J Hum Genet. 2025; 112, 1–15. 2. Kingsmore, Stephen F et al. NPJ Genomic Medicine vol. 9,1 17. 27 Feb. 2024. 3. French CE, Delon I, Dolling H, et al. Intensive Care Med. 2019 May;45(5):627-636.
*Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.